Validated using a knockout cell line
Recombinant
RabMAb

Anti-Peroxiredoxin 2 antibody [EPR5154] (ab109367)

Publishing research using ab109367? Please let us know so that we can cite the reference in this datasheet.

ab109367 has been referenced in 7 publications.

  • Chaudhuri R  et al. The transcriptional response to oxidative stress is part of, but not sufficient for, insulin resistance in adipocytes. Sci Rep 8:1774 (2018). WB ; Mouse . PubMed: 29379070
  • Fazakerley DJ  et al. Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance. Elife 7:N/A (2018). PubMed: 29402381
  • Khodaie N  et al. Combinatorial Preconditioning of Rat Brain Cultures with Subprotective Ethanol and Resveratrol Concentrations Promotes Synergistic Neuroprotection. Neurotox Res N/A:N/A (2018). PubMed: 29532445
  • Peng L  et al. Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients. Oncotarget 8:15057-15070 (2017). PubMed: 28125800
  • Viennois E  et al. Longitudinal study of circulating protein biomarkers in inflammatory bowel disease. J Proteomics 112:166-79 (2015). Mouse . PubMed: 25230104
  • Feng J  et al. Overexpression of peroxiredoxin 2 inhibits TGF-ß1-induced epithelial-mesenchymal transition and cell migration in colorectal cancer. Mol Med Rep 10:867-73 (2014). WB, IF ; Human . PubMed: 24920174
  • Zhou GL  et al. Deficits in receptor-mediated endocytosis and recycling in cells from mice with Gpr107 locus disruption. J Cell Sci 127:3916-27 (2014). Human . PubMed: 24849652

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up